Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic adipose-derived mesenchymal stem cells for draining fistulas in hidradenitis suppurativa
2020-004753-68Phase 2Active
- Sponsor
- Red Andaluza de Terapias Avanzadas
- Start
- Dec 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hidradenitis suppurativa (HS) comparing Allogeneic adipose-derived mesenchymal stem cells with Placebo (2 arms). Primary endpoint: Safety. Started Dec 2021; status: active.
02
Drugs
CSCC_ASC
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2020-004753-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004753-68.